RecruitingNCT06375941

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

Sponsor

Italian Sarcoma Group

Enrollment

250 participants

Start Date

Mar 29, 2024

Study Type

OBSERVATIONAL

Conditions

Angiosarcoma

Summary

This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.

Eligibility

Plain Language Summary

Simplified for easier understanding

This is an observational registry study collecting data on patients with angiosarcoma — a rare and aggressive cancer that can develop in blood vessels or lymphatic tissue — at any location in the body, to better understand how this disease behaves and how it is treated. **You may be eligible if...** - You have been diagnosed with angiosarcoma (confirmed by a pathologist) - Your tumor is at any site in the body - You are any age - Your disease is localized (has not spread) and can be surgically removed **You may NOT be eligible if...** - You do not have a confirmed pathological diagnosis of angiosarcoma - Your disease has already spread beyond the original site Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

Observational

Locations(19)

Istituto Clinico Humanitas Research Hospital IRCCS

Rozzano, Milano, Italy

Centro Riferimento Oncologico CRO

Aviano, Pordenone, Italy

AOU San Luigi Gonzaga

Orbassano, Torino, Italy

Istituto Tumori "Giovanni Paolo II" I.R.C.C.S.

Bari, Italy

Istituto Ortopedico Rizzoli IOR

Bologna, Italy

Policlinico "Sant'Orsola-Malpighi"

Bologna, Italy

A.O.U. Careggi

Florence, Italy

Ospedale Policlinico san Martino IRCCS

Genova, Italy

IRCCS Istituto Nazionale Tumori - Milano

Milan, Italy

IRCCS Istituto Europeo di Oncologia

Milan, Italy

Fondazione Irccs San Gerardo Dei Tintori

Monza, Italy

Istituto Nazionale Tumori_Fondazione "G.Pascale"

Naples, Italy

IOV Istituto Oncologico Veneto IRCCS

Padova, Italy

Policlinico "Paolo Giaccone"

Palermo, Italy

Nuovo Ospedale di Prato - S. Stefano

Prato, Italy

Fondazione Policlinico Campus Biomedico

Roma, Italy

IRCCS Istituti Fisioterapici Ospitalieri

Roma, Italy

ASL Ospedale San Giovanni Bosco

Torino, Italy

Ospedale di Trento

Trento, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06375941

Related Trials

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

NCT0104237942 locations

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT062392726 locations

Agnostic Therapy in Rare Solid Tumors

NCT066389318 locations

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

NCT068989701 location

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

NCT074329321 location